Kaynes Technology India Stock Price - ₹3,485.00 | Capital Goods

Kaynes Technology India is declining due to weak Q1 FY27 earnings, where net profit fell 32% year-over-year to ₹56.4 crore despite 40% revenue growth. The sell-off is driven by a sharp margin contraction to 6.0%, working capital stress in its smart metering segment, and delays in revenue from its OSAT and PCB businesses. Additionally, significant unwinding of derivative positions and broader market weakness in mid-cap stocks are exacerbating the downward pressure.

6h ago

‌
‌
‌

Company insights, generated from the most recent coverage.

Stock down 2.58% today with 6.43 lakh shares volume; MWPL fell 5.59% to 82.41%, indicating significant F&O unwinding adding to cash segment selling pressure.
Board seeking ₹7,000 crore loan limit at AGM on Sept 17, 2026, highlighting aggressive capex funding needs amid working capital stress.
CFO states ₹1,500 Cr PCB investment can unlock ₹15,000 Cr total business (₹1,500 Cr PCB + ₹13,500 Cr EMS), demonstrating how component manufacturing acts as a gateway to high-volume assembly contracts.
Read more

‌
‌
‌

The Quarter story

The two most recent quarterly results, compared side-by-side.

Kaynes Technology scales manufacturing capacity and order pipeline while navigating margin pressure and working capital delays.

Order book grew from ₹74,011 Cr to ₹89,038 Cr from Q1 FY26 to Q1 FY27 — strong pipeline supports future revenue.

Net profit margin declined from 11.1% to 6.0% from Q1 FY26 to Q1 FY27 — profitability faces ongoing compression.

OEM Turnkey PCBA revenue mix climbed from 1% to 51% from Q1 FY26 to Q1 FY27 — core manufacturing segment dominates sales.

Net working capital days worsened from 125 days to 163 days from Q4 FY26 to Q1 FY27 — cash conversion cycle slows down.

Railways revenue mix rose from 4% to 9% from Q1 FY26 to Q1 FY27 — infrastructure demand drives segment growth.

Gross margin slipped from 34.5% to 31.7% from Q3 FY26 to Q4 FY26 — rising input costs squeeze production profits.

EBITDA margin stabilized at 15.6% in Q1 FY27 after dipping to 14.5% in Q3 FY26 — pricing power remains intact.

ROCE fell from 15.4% to 11.6% from Q1 FY26 to Q1 FY27 — capital efficiency drops as heavy investments take time to yield returns.

Net debt to equity improved from 0.2x to 0.1x from Q1 FY26 to Q1 FY27 — balance sheet stays lean and manageable.

Medical revenue mix dropped from 7% to 2% from Q1 FY26 to Q1 FY27 — healthcare segment contribution shrinks significantly.

‌
‌
‌

In the news

Kaynes Tech Falls 5% on Investec Concerns; Jefferies Raises Target to ₹4,480

Kaynes Technology signs MoU with China's Bosgame for India entry

Kaynes Technology shares rise 2% after ECMS approval, plants set to go live

ECMS Scheme: Rs 7,877 Crore Boost to India's Electronics Manufacturing

Kaynes Tech Q1: 40% revenue growth, shares fall 3% on working capital concerns

Kaynes Tech Q1 profit drops 24% to ₹56 cr despite strong PCB demand

Market Experts' Stock Recommendations: Mixed Calls on Bharti Airtel, PB Fintech

India's ₹5.2L cr drone market may favor electronics firms

EMS stocks surge 7.5% on customs duty relief; Dixon hits 5-year high

Market experts recommend Maruti, Tata Steel for short-term gains

Kaynes Tech Shares Drop 56% as Jefferies Backs Component Focus

Kaynes Technology faces execution challenges despite healthy orders

Motilal Oswal Lists 6 EMS Stocks to Buy with Strong Growth Outlook

IEX Shares Rise 1.58% as May Trade Volumes Jump 19% YoY

Market Experts Share Stock Picks: Buy, Sell or Hold Ratings

Nifty hits 52-week low as Apollo Tyres, Kaynes, Tata Capital hit lows

Kaynes Technology shares fall 25% despite 26% revenue growth

Kaynes Tech shares tumble 25% after weak Q4, Elara cuts rating

Kaynes Tech dives 20% in 2 days as brokerages downgrade over cash flow woes

Kaynes Tech shares fall 5% after 20% crash on Q4 earnings miss

Kaynes Technology India

Insights

About the company

Insights